SFS
AIM

Sowell Financial Services’s AIM ImmunoTech AIM Stock Holding History

Sowell Financial Services’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3
Closed -$1K – 3452
2020
Q4 		$1K Buy
+3
New +$600 ﹤0.01% 2673

Other funds holding AIM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Sowell Financial Services's AIM Position: Q1 2021 in Review

Sowell Financial Services sold out of AIM ImmunoTech (AIM) in Q1 2021, closing a stake of 3 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in AIM in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 35 funds tracked by Wall St. Rank hold AIM as of Q1 2021.

  • Sowell Financial Services reported no remaining AIM ImmunoTech position as of Q1 2021 after selling out during the quarter.
  • Sowell Financial Services sold 3 AIM ImmunoTech shares in Q1 2021, an estimated $1K.
  • Sowell Financial Services first reported a position in AIM ImmunoTech in Q4 2020 and held it in 1 quarter.
  • Sowell Financial Services's AIM ImmunoTech position peaked at $1K in Q4 2020.
  • 35 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.